secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001493152-22-030066
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals appoints Dr. Bette Jacobs to Board, fills vacancy
-------------------------------------------------------------------------

- Appointed Dr. Bette Jacobs as independent director to fill vacancy left by William Adkins, effective Oct 28, 2022.
- Dr. Jacobs will serve on Audit Committee and Nominating and Corporate Governance Committee.
- Compensation includes $25,000 annual cash and $100,000 in RSUs vesting over three years.
- Board amended bylaws to reduce director term from three years to one year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315222030066/0001493152-22-030066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315222030066/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-030066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer